[14C] -RV521.HCl - A Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion Following a Single Oral Dose in Healthy Male Subjects
Latest Information Update: 26 May 2023
At a glance
- Drugs Sisunatovir (Primary)
- Indications Respiratory syncytial virus infections
- Focus Pharmacokinetics
- Sponsors Pfizer
Most Recent Events
- 26 May 2023 New trial record